Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles

Claudio Cabello-Verrugio*, María Gabriela Morales, Daniel Cabrera, Carlos P. Vio, Enrique Brandan

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology